Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, 110001, China.
Endocrine. 2023 Dec;82(3):457-466. doi: 10.1007/s12020-023-03466-9. Epub 2023 Oct 7.
There are conflicting reports on the factors that increase the likelihood of patients dying from follicular thyroid carcinoma (FTC). Therefore, it is critical to identify risk factors of patients with FTC. This study aimed to identify the factors that increase the risk of death of patients with FTC and help clinicians make better treatment and follow-up decisions.
A systematic literature review was conducted in PubMed and Web of Science databases for relevant studies published before January 31, 2023. Their reference lists were also analyzed. Two reviewers extracted data and evaluated the quality of eligible studies independently. Studies on patients who had open thyroidectomy procedures with or without neck dissection were included in this review. The RevMan 5.3 software was used to analyze the data.
This meta-analysis included thirteen studies with a total of 2075 patients. The following variables were associated with an increased risk of death in FTC patients: age > 45 years, male, tumor diameter > 4 cm, multifocality, extrathyroidal extension (ETE), widely invasive (WI), cervical lymph node metastasis (CLNM), distant metastases (DM) and non-radical resection tumor. Lobectomy and no radioactive iodine (RAI) treatment was not associated with the death of FTC patients.
Clinicians should pay closer attention to the following significant risk factors associated with the death of FTC patients: age (> 45), male, multifocality, tumor diameter > 4 cm, ETE, WI, non-radical resection tumor, CLNM, and DM. Individualized initial treatment and close follow-up are needed FTC patients who have these risk factors.
关于增加滤泡状甲状腺癌(FTC)患者死亡风险的因素存在相互矛盾的报告。因此,确定 FTC 患者的风险因素至关重要。本研究旨在确定增加 FTC 患者死亡风险的因素,帮助临床医生做出更好的治疗和随访决策。
在 PubMed 和 Web of Science 数据库中进行了系统的文献回顾,以检索截至 2023 年 1 月 31 日发表的相关研究。还分析了它们的参考文献列表。两位审查员独立提取数据并评估合格研究的质量。本综述纳入了接受甲状腺切除术(伴或不伴颈部清扫术)的患者的研究。使用 RevMan 5.3 软件分析数据。
本荟萃分析共纳入 13 项研究,共计 2075 例患者。以下变量与 FTC 患者死亡风险增加相关:年龄>45 岁、男性、肿瘤直径>4cm、多灶性、甲状腺外侵犯(ETE)、广泛浸润(WI)、颈淋巴结转移(CLNM)、远处转移(DM)和非根治性切除肿瘤。甲状腺叶切除术和无放射性碘(RAI)治疗与 FTC 患者的死亡无关。
临床医生应更加关注与 FTC 患者死亡相关的以下显著风险因素:年龄(>45 岁)、男性、多灶性、肿瘤直径>4cm、ETE、WI、非根治性切除肿瘤、CLNM 和 DM。对于具有这些风险因素的 FTC 患者,需要个体化的初始治疗和密切随访。